PEP Packs: Postexposure Prophylaxis Packs for Immediate Access to HIV and Sexually Transmitted Infection Prevention
ID: 355903Type: Posted
Overview

Buyer

Centers for Disease Control and Prevention - ERA (HHS-CDC-HHSCDCERA)

Award Range

$900K - $1M

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The Centers for Disease Control and Prevention (CDC) has announced a funding opportunity titled "PEP Packs: Postexposure Prophylaxis Packs for Immediate Access to HIV and Sexually Transmitted Infection Prevention." This initiative aims to support an implementation research study that evaluates strategies for integrating Postexposure Prophylaxis (PEP) packs into existing Pre-exposure Prophylaxis (PrEP) services, specifically targeting populations disproportionately affected by HIV, such as Black and Hispanic men who have sex with men (MSM) and transgender women (TGW). The program seeks to enhance access to nonoccupational PEP (nPEP) and includes the provision of starter kits containing nPEP medications, STI prophylaxis treatment, and self-testing kits to facilitate immediate prevention following potential exposures. The total funding available for this opportunity is $4.8 million, with a single award anticipated, and applications must be submitted electronically by February 19, 2025. For further inquiries, interested parties can contact Jocelyn Patterson Mosley at JPatterson@cdc.gov.

    Point(s) of Contact
    Files
    Title
    Posted
    The CDC's National Center for HIV, Viral Hepatitis, STD, and TB Prevention has issued a Notice of Funding Opportunity (RFA-PS-25-112) to implement and evaluate a strategy for integrating Postexposure Prophylaxis (Pep) Packs into existing Pre-exposure Prophylaxis (PrEP) services. This initiative aims to enhance access to nonoccupational postexposure prophylaxis (nPEP) for populations disproportionately affected by HIV, specifically Black and Hispanic men who have sex with men (MSM) and transgender women (TGW). The PiP approach consists of providing starter kits containing nPEP medications, STI prophylaxis treatment, and self-testing kits, fostering immediate prevention following potential exposures. The funding opportunity anticipates one award, totaling $4.8 million across four years, to support research activities focusing on timely nPEP initiation, user acceptance of PEP packs, and clinical service quality. Eligible organizations include state and local governments, non-profits, and public educational institutions. Applications must be submitted electronically by February 19, 2025. By improving access and reducing systemic barriers to prompt care, this initiative aligns with national public health goals to decrease HIV infections and improve health outcomes for marginalized populations.
    Similar Opportunities
    Demonstration Projects for Comprehensive and Integrated HIV Care, Treatment, Prevention and Essential Support Service Models for Cis-gender Black Women (CgBW) in the South
    Centers for Disease Control - NCHHSTP
    The Centers for Disease Control and Prevention (CDC) is forecasting a grant opportunity titled "Demonstration Projects for Comprehensive and Integrated HIV Care, Treatment, Prevention and Essential Support Service Models for Cis-gender Black Women (CgBW) in the South." This initiative aims to address the significant health disparities faced by CgBW, who represent the largest percentage of women living with HIV in the U.S., by funding organizations to implement integrated care service models through Community and Clinic Collaboratives (CCCs). The project will focus on providing comprehensive health services, including HIV care, mental health support, and essential services, while fostering culturally responsive practices and sharing best practices through a national learning collaborative. The estimated total program funding is $7.5 million, with three awards expected, and applications must be submitted electronically by March 28, 2025, to be considered for funding. For further inquiries, interested applicants can contact Jerris Raiford at (770) 488-0691 or via email at HRBNOFO@cdc.gov.
    Support strengthening and utilization of strategic information activities in the Republic of South Africa (SA) under the President’s Emergency Plan for AIDS Relief (PEPFAR)
    Centers for Disease Control-GHC
    The Centers for Disease Control and Prevention (CDC) is offering a cooperative agreement to support the strengthening and utilization of strategic information activities in the Republic of South Africa under the President’s Emergency Plan for AIDS Relief (PEPFAR). The primary objective of this funding opportunity is to provide reliable and timely data for monitoring progress towards ending HIV as a public health threat, which will inform program planning and improve the capacity of the South African government to collect and utilize high-quality data. This initiative is crucial for guiding HIV-related policies and interventions, ultimately aiming to reduce the burden of HIV and tuberculosis (TB) epidemics in South Africa. Interested applicants should note that the estimated total program funding for Year 1 is approximately $1,000,000, with a close date for applications set for March 31, 2025. For further inquiries, applicants can contact Emily Dale at pepfarfoas@cdc.gov.
    Capacity building, technical assistance and workforce training to rapidly and effectively address health threats and to accelerate the response to HIV in the United Republic of Tanzania under the President's Emergency Plan for AIDS Relief (PEPFAR)
    Centers for Disease Control-GHC
    The Centers for Disease Control and Prevention (CDC) is forecasting a federal grant opportunity aimed at capacity building, technical assistance, and workforce training to enhance the response to health threats, particularly HIV, in the United Republic of Tanzania under the President's Emergency Plan for AIDS Relief (PEPFAR). The objective of this cooperative agreement is to strengthen the capabilities of Tanzanian public health institutions to effectively manage and lead the ongoing HIV response, ensuring the provision of comprehensive and high-quality services while minimizing new infections and improving the quality of life for individuals living with HIV. This initiative is crucial for enhancing public health infrastructure and sustainability in Tanzania, with an anticipated funding amount of approximately $1,000,000 for the first year, subject to availability. Interested applicants can reach out to Emily Dale at (404) 639-8880 or via email at pepfarfoas@cdc.gov for further details, with applications due by February 17, 2025, and an estimated award date of September 30, 2025.
    Capacity Building to sustain HIV epidemic control under PEPFAR
    Health Resources and Services Administration
    The Health Resources and Services Administration (HRSA) is forecasting a federal grant opportunity titled "Capacity Building to sustain HIV epidemic control under PEPFAR." This initiative aims to establish a network of organizations that will provide tailored technical assistance to support the accelerated and sustained control of the HIV epidemic across PEPFAR countries. The program is critical for enhancing health outcomes and ensuring effective responses to the HIV epidemic, with an estimated total funding of $2 million available for approximately five awards. Interested applicants, including public and private entities, can reach out to the Office of Global Health at HRSA via email at hrsa@hrsa.gov or by phone at 301-443-0000, with the synopsis expected to be posted on February 20, 2025, and applications closing on May 21, 2025.
    HIV Prevention and Alcohol (R01 Clinical Trials Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "HIV Prevention and Alcohol (R01 Clinical Trials Optional)" aimed at expanding HIV prevention strategies among populations affected by alcohol use. This initiative encourages research projects that explore the relationship between alcohol consumption and HIV risk behaviors, focusing on areas such as Pre-exposure Prophylaxis (PrEP) utilization, Treatment as Prevention (TasP), and the integration of preventive intervention strategies. The program is particularly significant for addressing health disparities among high-risk groups, including men who have sex with men (MSM) and women with high-risk partners. The NIH anticipates funding between $2 million for 2 to 4 awards, with a project period of up to five years. Interested applicants can submit their proposals through the NIH ASSIST system or Grants.gov, and should direct inquiries to grantsinfo@nih.gov. The application deadline is May 7, 2026.
    Human resources for health (HRH) to achieve and sustain TB/HIV epidemic control in Malawi under the President's Emergency Plan for AIDS Relief (PEPFAR)
    Centers for Disease Control-GHC
    The Centers for Disease Control and Prevention (CDC) is forecasting a cooperative agreement opportunity titled "Human resources for health (HRH) to achieve and sustain TB/HIV epidemic control in Malawi" under the President's Emergency Plan for AIDS Relief (PEPFAR). This initiative aims to strengthen leadership and management capacity, as well as monitoring and evaluation systems for the HIV response in Malawi, focusing on hiring and seconding human resources at the national level to manage and lead the national HIV/TB prevention, care, and treatment program. The program is critical for developing a sustainable HRH information system and enhancing existing health workforce capabilities without hiring new site-level healthcare workers. Interested applicants can reach out to Emily Dale at (404) 639-8880 or via email at pepfarfoas@cdc.gov. The estimated total funding for the first year is approximately $3,000,000, with applications due by February 17, 2025, and awards expected to be announced by September 30, 2025.
    Engaging faith-based organizations to control the HIV epidemic and related health threats in the Republic of Uganda under the President's Emergency Plan for AIDS Relief (PEPFAR)
    Centers for Disease Control-GHC
    The Centers for Disease Control and Prevention (CDC) is forecasting a cooperative agreement opportunity aimed at engaging faith-based organizations to combat the HIV epidemic and related health threats in Uganda under the President's Emergency Plan for AIDS Relief (PEPFAR). The initiative seeks to strengthen health systems and implement comprehensive programs for HIV, TB, and related health services, focusing on improving access, quality, and uptake of these services while achieving the 95-95-95 targets for HIV management. With an anticipated total funding amount of $10 million for the first fiscal year, the CDC expects to award three grants, with applications due by February 17, 2025, and the estimated award date set for September 30, 2025. Interested applicants can reach out to Emily Dale at 404-639-8880 or via email at pepfarfoas@cdc.gov for further information.
    Addressing Stigma to End the HIV Epidemic in the U.S.
    Health Resources and Services Administration
    The Health Resources and Services Administration (HRSA) is offering a funding opportunity titled "Addressing Stigma to End the HIV Epidemic in the U.S." aimed at supporting an organization that will implement, train, and evaluate anti-stigma interventions to enhance access to HIV care for underserved populations. The selected recipient will manage approximately 20 demonstration sites, facilitate national training, and develop a robust evaluation framework to assess the impact of these interventions over a four-year performance period, with a total funding amount of $25.25 million. This initiative is crucial for improving health outcomes by reducing stigma within healthcare systems, thereby increasing the availability of high-quality care, treatment, and prevention services for individuals affected by HIV. Interested applicants, including public and private nonprofits, state and local governments, and educational institutions, must submit their proposals by March 18, 2025, with the funded program expected to commence on September 1, 2025. For further inquiries, contact LaQuanta Smalley at SPNS@hrsa.gov.
    Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R34 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services," aimed at supporting innovative research to enhance the integration of HIV, addiction, and primary care services. This initiative invites applications for R34 Planning Grants to develop and test models that improve healthcare delivery for individuals at risk for or living with HIV, Hepatitis B and C, and substance use disorders, with a focus on strategies such as integrating substance misuse prevention within HIV care settings. The total funding available for this project is $2 million, with awards potentially lasting up to three years, and applications are due by March 20, 2025. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.
    Reducing the burden of parasitic infections in the United States through evidence-based prevention and control activities
    Centers for Disease Control - NCEZID
    The Centers for Disease Control and Prevention (CDC) is forecasting a federal grant opportunity aimed at reducing the burden of parasitic infections in the United States through evidence-based prevention and control activities. This initiative, structured as a cooperative agreement, focuses on three key components: enhancing healthcare provider knowledge and practices regarding Chagas disease, expanding public health surveillance for soil-transmitted helminths, and addressing other significant parasitic diseases of domestic concern. With an estimated total program funding of $10 million and an award ceiling of $1 million, the CDC anticipates making approximately seven awards, with applications due by May 2, 2025. Interested applicants can reach out to Emily Dodd at 404-639-3753 or via email at iog2@cdc.gov for further information.